Integrative Pancreatic Intervention Therapy: A Holistic Approach. This item is unavailable.Integrative Pancreatic Intervention Therapy: A Holistic Approach

Integrative Pancreatic Intervention Therapy: A Holistic Approach summarizes, in a systematic manner, the diagnosis and treatment of late, critical pancreatic diseases. The book gives insights into each interventional technique, with an ultimate goal of improving survival rates for late stage pancreatic cancer patients. Six sections cover basic and transformation research on pancreatic diseases, interventional therapy for benign pancreatic disease, interventional therapy for malignant pancreatic diseases, interventional therapy for pancreative cancer-related lesions, stem cell and targeted molecular therapy for pancreative carcinoma, and combined interventional therapy for pancreative carcinoma.

This book will be useful for those looking to understand how best to apply interventional therapy for the improvement of late state pancreatic cancer treatment.

• Gives a step-by-step account of interventional therapy in late stage pancreatic cancer
• Presents research on interventional techniques for plotting a management plan for late stage pancreatic cancer patients
• Provides fundamental research in pancreatic cancer on the genes and signaling pathways relating to tumorigenesis and metastasis of advanced pancreatic cancer
• Considers the combination of different interventional techniques to achieve better survival rates and increase quality of life for patients
• Assesses the usefulness of combining interventional therapies into a holistic treatment approach

Maoquan Li is Professor in the Department of Interventional and Vascular Therapy at Shanghai Tenth People’s Hospital at Tongji University. He specializes in interventional radiology. He was the first interventional radiologist in China to conduct interventional treatment of gastric cancer, adrenal tumors, embolization of uterine fibroids, rheological thrombolytic therapy, interventional comprehensive therapy for diabetic vascular disease, interventional comprehensive treatment for chronic thrombus, and the molecular targeted therapy of aesthetic liver cancer. He is a leader in the field.

Ligong Lu is Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. He is deputy director of the Institute of Interventional Vascular Research, and Director of the Zhuhai Intervention Centre, and the Zhuhai Precision Medical Treatment Centre. He is a doctoral tutor at Jinan University, Southern Medical University, and Guangdong Provincial Institute of Cardiovascular Disease, as well as a Professor at Macao University. He has been a senior visiting scholar at the Wayne State University Detroit Medical Center. His research focuses on basic and clinical interventional radiology, liver cancer, and malignancies.

Yueyong Xiao is Deputy Director of Radiology at Shanghai Military Hospital. He is Chief Physician, and a doctoral tutor, as well as an executive member of the International Refrigeration Association, and President of the Asian Frozen Society. His work in imaging diagnosis and interventional therapy spans 30 years. He carries out CT and MRI guided minimal invasive surgery. He has been a senior visiting scholar at Harvard Medical College, specializing in CT, and MRI-guided interventional therapy.

Deliang Fu is the Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University in China, and the Director of the Pancreatic Cancer Treatment Center at Fudan University. He is also deputy director of the Institute of Pancreatic Diseases, also at Fudan University, and vice-chairman of the Pancreas Division of the Shanghai Medical Association, as well as a doctoral tutor. He has published widely in the field, both research papers and book chapters, and has led a number of National Natural Science Foundation and Ministry of Health research projects.

Haijun Zhang is Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, at Tongji University in China. He is also Director of the strategic alliance for the medical material modification industry. He focuses on biomedical material modification, including in medical material engineering, medical engineering, and transformational medicine.